dihexa half-life Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive/Antidementia Agents AngIV-Analog Dihexa Rescues Cognitive Impairment
Description
No claims are made regarding therapeutic application, clinical relevance, physiological outcomes, or suitability for human or veterinary use
BPC-157 works through VEGFR2-Akt-eNOS signaling and nitric oxide production
Rodent (lean diet combination) Sampson et al
Sep 2017;14(9):1095-1103
& Kano, M
Stupnisek et al., 2015
